Europe Ultrasound Device Market Analysis

Europe's ultrasound device market was valued at US$ 2.47 billion in 2023 and is projected to reach US$ 3.95 billion by 2032, with a compound annual growth rate (CAGR) of 5.32% from 2024 to 2032. The market's growth is driven by the increasing use of diagnostic imaging and advancements in ultrasound technology within Europe's healthcare system. Ultrasound technology is gaining popularity in the healthcare industry due to its non-invasiveness, cost-effectiveness, speedy results, and safety compared to other imaging techniques.

Europe Ultrasound Device Market Overview

An ultrasound device is a medical imaging tool that uses high-frequency sound waves to create images of structures within the body. It is widely used in diagnostic imaging for various applications, including obstetrics, cardiology, musculoskeletal, and abdominal scans. Ultrasound devices are non-invasive and radiation-free, making them safe for a wide range of patients, including pregnant women. The technology works by transmitting sound waves into the body, which bounce off tissues and organs, creating images that healthcare providers use for diagnosis and monitoring.

Request a free sample copy of the report: https://www.renub.com/europe-ultrasound-devices-market-p.php

In Europe, ultrasound devices are extensively used in public and private healthcare settings. With a strong focus on preventive care, European countries deploy ultrasound technology for routine screenings, particularly in obstetrics and gynecology. Additionally, the increasing elderly population in Europe drives the demand for ultrasound devices in cardiovascular and musculoskeletal assessments. Continuous technological advancements, such as portable and 3D/4D ultrasound systems, further enhance their adoption across the region.

Growth Factors in the European Ultrasound Device Industry

Rising Demand for Preventive Healthcare and Early Diagnosis

The increasing emphasis on preventive healthcare across Europe drives the demand for ultrasound devices. Governments and healthcare providers focus on early diagnosis to improve patient outcomes and reduce long-term healthcare costs. Ultrasound technology is widely adopted for routine screenings, especially in obstetrics, gynecology, and cardiovascular assessments. The non-invasive nature and real-time imaging capability of ultrasound devices make them a preferred tool for the early detection of conditions like tumors, cysts, and fetal abnormalities. As preventive care becomes a priority, the need for efficient and accessible imaging solutions is fueling growth in the European ultrasound device market.

Technological Advancements and Innovation

Technological advancements, such as developing portable, 3D/4D, and AI-powered ultrasound devices, significantly boost the European market. Portable handheld devices allow for more flexible and point-of-care applications, especially in remote or underserved areas. Advanced imaging capabilities, such as 3D/4D, provide more precise, more detailed views, enhancing diagnostic accuracy, particularly in prenatal care and complex medical conditions. Integrating artificial intelligence (AI) in ultrasound systems helps automate image analysis and improve diagnostic efficiency. These innovations drive the adoption of ultrasound devices across Europe, making them more accessible and practical for diverse healthcare needs.

Growing Geriatric Population and Chronic Disease Burden

Europe's aging population is a significant factor driving the ultrasound device market. As the elderly population increases, the incidence of chronic conditions such as cardiovascular diseases, musculoskeletal disorders, and cancer rises. Ultrasound devices are essential for diagnosing and monitoring these conditions, offering a non-invasive, cost-effective solution. The growing need for regular imaging in chronic disease management and elderly care is expanding the use of ultrasound technology in hospitals, clinics, and long-term care settings. This demographic shift is expected to sustain the growth of the ultrasound device industry across Europe in the coming years.

France Ultrasound Device Market

The French ultrasound device market is experiencing steady growth driven by advancements in medical technology and increasing demand for diagnostic imaging. The expansion of healthcare infrastructure and a rising focus on early disease detection are significant factors contributing to this trend. Innovations in ultrasound technology, such as portable and high-resolution devices, are enhancing diagnostic accuracy and patient convenience. Additionally, the aging population in France is creating a higher demand for ultrasound services to manage age-related health conditions. Government initiatives to improve healthcare accessibility and affordability further support market growth. Key players in the market are investing in research and development to introduce advanced products and maintain a competitive edge. As a result, the France ultrasound device market is expected to continue evolving, offering new opportunities for healthcare providers and driving advancements in patient care.

Europe Ultrasound Device Market Company Overview

Some industry leaders in the Europe Ultrasound Device Market include Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Philips Healthcare, Samsung, Siemens Healthcare, Canon Medical Systems Corporation, and Mindray Medical International Limited.

Europe Ultrasound Device Market News

In October 2023, Razom and Butterfly Network, Inc. announced that they are expanding their global health cooperation to include the delivery of 200 Butterfly iQ+ ultrasound units to Ukrainian front-line medical personnel. This collaboration is a sign of both businesses' dedication to providing Ukraine with high-quality, easily accessible healthcare.

In December 2022, the establishment of Siemens Healthineers AG's first ultrasound production facility in Europe was announced. The facility was designed to be utilized by the company to produce some parts of all general imaging & cardiovascular ultrasound systems, with a capacity of 120 systems per week.

In May 2022, seven new ultra-portable wireless ultrasound scanners for Apple and Android devices have achieved CE mark approval from Clarius.

Related Report:

Ultrasound Device Market: https://www.renub.com/ultrasound-device-market-p.php

United States Ultrasound Devices Market: https://www.renub.com/united-states-ultrasound-devices-market-p.php

China Ultrasound Device Market: https://www.renub.com/china-ultrasound-devices-market-p.php

Application – Market breakup in 6 viewpoints:

1. Anesthesiology

2. Cardiology

3. Gynecology/Obstetrics

4. Musculoskeletal

5. Vascular

6. Others

Technology – Market breakup in 4 viewpoints:

1. 2D Ultrasound Imaging

2. 3D and 4D Ultrasound Imaging

3. Doppler Imaging

4. High-intensity Focused Ultrasound

Types– Market breakup in 2 viewpoints:

1. Stationary Ultrasound

2. Portable Ultrasound

End Users – Market breakup in 3 viewpoints:

1. Hospitals

2. Diagnostic Centers

3. Other End Users

Country – Market breakup in 6 viewpoints:

Europe

o Germany

o United Kingdom

o France

o Italy

o Spain

o Rest of Europe

All the Key players have been covered from 4 Viewpoints:

1. Overviews

2. Recent Developments & Strategies

3. Product Portfolio & Product Launch in Last 1 Year

4. Revenue

Company Analysis:

1. Fujifilm Holdings Corporation

2. GE Healthcare

3. Hitachi Medical Corporation

4. Philips Healthcare

5. Samsung

6. Siemens Healthcare

7. Canon Medical Systems Corporation

8. Mindray Medical International Limited

About the Company:

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.